Abstract

Cerebral vasospasm is a critical determinant in the prognosis of subarachnoid hemorrhage (SAH). Increased vascular reactivity plays a key role in cerebral vasospasm. Not only enhanced contraction, but also prolonged contraction are characteristic of cerebral vasospasm. The up-regulation of GPCRs, including thrombin receptor PAR 1 , contributes to enhanced contraction. The present study addressed the hypothesis that changes in the mechanisms regulating the activity of GPCRs contribute to a prolonged vascular reactivity. This study used a rabbit double SAH model. PAR 1 -activating peptide (PAR 1 AP) induced a transient contraction in the control basilar arteries, while it induced an enhanced and sustained contraction in SAH. When sequentially applied, the second stimulation of PAR 1 AP induced 75% of the first response, while it induced an 8% response in the controls. Thrombin induced an enhanced and sustained contraction in SAH. Notably, the thrombin-induced contraction persisted irreversibly even after terminating thrombin stimulation. The responses to angiotensin II, vasopressin, and PGF 2 α were also enhanced and prolonged to varying degrees after SAH. These observations suggested that, in addition to receptor up-regulation, the mechanism for the desensitization of GPCRs was impaired during SAH. Intrathecal treatment with argatroban, a thrombin inhibitor, prevented the enhancement of the response to PAR 1 agonists in SAH. However, PAR 1 AP still induced a sustained response, the reactivity to the second stimulation was maintained, and thrombin induced an irreversible contraction. Addition of vitamin C or tempol to argatroban restored a transient response, tachyphylactic attenuation, and reversibility of thrombin response. The level of oxidative stress in the brain tissues increased after SAH, and it was normalized by either argatroban or vitamin C. The results suggest that oxidative stress impairs the desensitization of GPCRs, thus prolonging vascular reactivity after SAH. The impaired desensitization significantly influenced the activity of PAR 1 , thereby causing irreversible contraction. Combined thrombin inhibition and anti-oxidative agents is therefore considered to be a novel strategy to normalize vascular reactivity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.